Panglobulin NF Interactions
There are 107 drugs known to interact with Panglobulin NF (immune globulin intravenous), along with 3 disease interactions. Of the total drug interactions, 86 are major, and 21 are moderate.
- View Panglobulin NF disease interactions (3)
Medications known to interact with Panglobulin NF
Note: Showing generic names only.
A
- adefovir
- amikacin
- amikacin liposome
- amphotericin b
- amphotericin b cholesteryl sulfate
- amphotericin b lipid complex
- amphotericin b liposomal
B
C
- capreomycin
- carboplatin
- celecoxib
- chikungunya vaccine, live (cvx 317)
- cholera vaccine, live
- cidofovir
- cisplatin
- colistimethate
- cyclosporine
D
E
F
G
I
- ibandronate
- ibuprofen
- indomethacin
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, live
- inotersen
- iobenguane I 131
K
L
M
- measles virus vaccine
- meclofenamate
- mefenamic acid
- meloxicam
- mephenytoin
- mesalamine
- methotrexate
- methoxyflurane
- monomethyl fumarate
- moxetumomab pasudotox
- mumps virus vaccine
N
O
P
- pamidronate
- pentamidine
- phenylbutazone
- phenytoin
- piroxicam
- plazomicin
- poliovirus vaccine, live, trivalent
- polymyxin b
- pozelimab
R
S
T
- tacrolimus
- telavancin
- temsirolimus
- tenofovir alafenamide
- tenofovir disoproxil
- tobramycin
- tolmetin
- typhoid vaccine, live
V
Y
Z
Panglobulin NF disease interactions
There are 3 disease interactions with Panglobulin NF (immune globulin intravenous) which include:
Report options
QR code containing a link to this page
More about Panglobulin NF (immune globulin intravenous)
- Compare alternatives
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: immune globulins
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.